Matrine Sodium Chloride Injection

In the liver injury model caused by carbon tetrachloride, this product can reduce the serum transaminase and hydroxyproline content in the liver of animals, alleviate the degree of liver lesions and reduce the serum DHBV-DNA level of ducks infected with hepatitis B virus (HBV).

The main ingredient of this product is matrine, also known as oxymatrine.

This product is a colorless or almost colorless clear liquid.

Used for the treatment of chronic hepatitis B.

Intravenous drip: once a day, 0.4-0.6g each time.

The incidence of adverse reactions is low. Common adverse reactions include dizziness, nausea, vomiting, bitter taste in the mouth, diarrhea, upper abdominal discomfort or pain, and occasionally rash, chest tightness, and fever. Symptoms generally resolve on their own. Some patients may experience redness at the injection site.

1. Patients who are allergic to this product are prohibited from using it. 2. Patients with severe blood, heart, liver, kidney and endocrine diseases are prohibited from using it.

It has a synergistic effect with central nervous system depressants such as chloral hydrate, an antagonistic effect on central nervous system stimulants such as amphetamine, and can facilitate the convulsive effect of strychnine.

Keep in a sealed container. The validity period is tentatively set at one year.

50ml: 0.3g of matrine (calculated as oxymatrine) and 0.45g of sodium chloride

NORTHEAST Pharmaceutical Group Shenyang NO.1 Pharmaceutical Co., Ltd.

• Founded in:

  1989-01-25

• Address:

  No. 8 Kunming Lake Street, Shenyang Economic and Technological Development Zone

• Tax NO.:

  91210106242656694M

• Registered Funds:

  80 million yuan

• Website:

  Log in to view

• Email:

  Log in to view